Results 1 to 10 of about 11,077 (219)
Examining the Relationship Between CDAI and Frailty and Its Manifestation in Parkinson’s Disease: A Cross-Sectional Study [PDF]
Frontiers in NutritionBackgroundHigher intake of antioxidants is associated with reduced risk of various chronic diseases. However, the relationship between composite dietary antioxidants and frailty has not been characterized, especially in neurodegenerative conditions like Parkinson’s disease (PD) where frailty is highly prevalent.
Zhaohao Zeng, Guo Hong, Guoyang Li
exaly +5 more sources
Visualization of DAS28, SDAI, and CDAI: The Magic Carpets of Rheumatoid Arthritis [PDF]
Clinical Rheumatology, 2014 There has been continuous debate regarding the applicability of various composite measures for the assessment of disease activity in rheumatoid arthritis (RA). In order to further dissect this issue, we numerically and graphically modeled 28-joint disease activity scale (DAS28), simplified disease activity index (SDAI), and clinical disease activity ...
Zoltán Szekanecz
exaly +3 more sources
Rheumatoid Arthritis Effects on Kidney and Liver and Their Correlations With CDAI
Journal of Techniques, 2022 Rheumatoid arthritis (RA) is a disease characterized by chronic autoimmune inflammation of body joints, causing movement disability, loss of functions, joint damage, and many complications. Persistent usage of anti-rheumatic drugs has several side effects, which may cause heart, kidney, or liver diseases.
Ali Hussein Al-Hafidh
exaly +3 more sources
A Clinical Study on the Use of Methotrexate in Rheumatoid Arthritis Based on CDAI Score
Journal of Drug Delivery and Therapeutics, 2022 Methotrexate (MTX) has been used in the treatment of rheumatoid arthritis for more than 2 decades. It has proven its efficacy in the treatment of rheumatoid arthritis in numerous randomized controlled trials. Compared with other second-line drugs, a higher percentage of patients can continue therapy with MTX over a prolonged period.
K Bhavy +4 more
exaly +2 more sources
Definition of Rheumatoid Arthritis Flare Based on SDAI and CDAI
Annals of the Rheumatic DiseasesTo develop and validate definitions for disease flares in rheumatoid arthritis (RA) based on the quantitative Simplified and Clinical Disease Activity Indices (SDAI, CDAI).We analysed RA treatment courses from the Norwegian disease-modifying antirheumatic drug registry (NOR-DMARD) and the Vienna RA cohort.
Sella Provan +2 more
exaly +3 more sources
The role of timely rheumatoid arthritis treatment effectiveness control
Consilium Medicum, 2023 Background. Regular assessment of rheumatoid arthritis (RA) activity is a key factor in therapy effectiveness improving. Aim. To prove that timely RA treatment control recommended by modern guidelines improves outcomes and reduce disability in real ...
Larisa M. Musaeva +3 more
doaj +1 more source
THE ASSESSMENT OF MRE FINDINGS ACCORDING TO CDAI SCORE IN PATIENTS WITH CROHN’S DISEASE [PDF]
Gastroenterology, 2022 Abstract INTRODUCTION Crohn’s disease (CD) is a chronic inflammatory bowel disease of the gastrointestinal tract. One of the diagnostic steps is to perform a magnetic resonance enterography (MRE). The purpose of the study was to compare MRE findings with clinical index of the disease activity - CDAI ...
Monika Zbroja +6 more
openaire +1 more source
Antioxidants, 2023 The relationship between composite dietary antioxidant index (CDAI) levels and the risk of atherosclerotic cardiovascular disease (ASCVD) in postmenopausal women is unknown.
Chenning Liu +4 more
doaj +1 more source
Научно-практическая ревматология, 2012 Objective: to evaluate the clinical efficiency of tocilizumab (TCZ) versus rituximab (RTM) therapy using DAS 28, SDAI, and CDAI scores and to estimate remission rates using DAS 28 and the remission criteria proposed by the European League Against ...
Anastasia Sergeyevna Avdeyeva +4 more
doaj +1 more source
Impact of tocilizumab therapy on immunological parameters in patients with rheumatoid arthritis
Научно-практическая ревматология, 2012 Objective: to evaluate the impact of tocilizumab (TCZ) therapy on the level of acute-phase indicators, autoantibodies, and immunoglobulins (Ig) G, M, and A after 2, 4, 8, 12, and 24 weeks as compared to the clinical efficacy of TCZ using DAS 28, SDAI ...
Anastasia Sergeyevna Avdeyeva +5 more
doaj +1 more source